Azimilide

ASAP Studie mit Azimilide bei Vorhofflimmern,hier werden wichtige wissenschaftliche Therapiestudien dargestellt. von CM Pratt - Zitiert durch:

23 Oct 2009 ... 14 Nov 2001 ... Investigational Antiarrhythmic Azimilide Demonstrates No Adverse Effect On Mortality In Post-Myocardial Infarction Patients. von AE Busch - 1998 - Zitiert durch: Eight patients in the Sotalol ( 3.5% ) and 16 in the Azimilide ( 7.6% ) group interrupted the study because of QTc prolongation. Stedicor® Cardiology An antiarrhythmic used for A Fib, supraventricular arrhythmias, and to prevent sudden cardiac death in post-MI Pts. See ALIVE, ASAP . von R Abrol - 2000 - Zitiert durch:

Azimilide is a class III antiarrhythmic agent which blocks both the ...

The goal of this study was to determine whether azimilide, as compared with placebo, will reduce the... Azimilide (n=211), Sotalol (n=223), Placebo (n=224), Azimilide (n=211) (%), Sotalol (n=223), Placebo (n=224). Deaths, 0, 1, 0, 4 (1. von M El Mouelhi - 2003 - Zitiert durch: von ELC PRITCHETT - 2002 - Zitiert durch: Order from the British Library: Azimilide for the Treatment of Atrial Fibrillation, Atrial Flutter, and Paroxysmal Supraventricular Tachycardia:

Atevirdine Blogs.

von S Nattel - 1998 - Zitiert durch: Dateiformat: von RL Page - 2003 - Zitiert durch: von CM Pratt - 2006 - Zitiert durch: von CM Pratt - 2004 - Zitiert durch: Looking For China azimilide Manufacturers,azimilide Wholesalers,india azimilide Exporters,factories, Suppliers,Companies and Distributors ? Come Here Now !

1 Eintrag - Letzter Eintrag: 8. Jan. 1999This is a discussion on MedHelp about Azimilide. Article Type: Abstract, Publication: Journal of the American College of Cardiology, Author/s: von M El-Mouelhi - Zitiert durch: Azimilide is a class ΙΙΙ antiarrhythmic drug (used to control abnormal heart rhythms). 5 Dec 2008 ... The drug that is farthest along is azimilide, a new antiarrhythmic agent with Class III activity that is not yet approved by the U.S. von A Corey - 1997 - Zitiert durch:

von CM Pratt - 2006 - Zitiert durch:

Azimilide: A nonselective class III antiarrhythmic agent for use in atrial fibrillation ... find Formulary articles.

Dofetilide and azimilide have caused Dr.

von CA Carnes - 2000 - Zitiert durch:

Azimilide, Disease Database Information. ... Azimilide. belongs to the drug family of + (Follow link for list.

Azimilide, Dossier erstellt im SS 1999. Firmeninformationen. Hersteller, Procter&Gamble. Handelsnamen®, Stedicor.

von ELC Pritchett - 2003 - Zitiert durch: von A Nishida - 2007 - Zitiert durch:

Dateiformat:

Background Azimilide reportedly blocks Na+ channels, although its mechanism remains unclear. American Journal of Cardiology, Volume 98, Issue 2, Pages 215-218, 15 July 2006, Authors:Charles R. Kerr; Stuart J. Connolly; Peter Kowey; Richard L. von F Chen - 2002 - Zitiert durch: Free Online Library: AZIMILIDE PROLONGS ARRHYTHMIA-FREE PERIODS. by "Biotech Business"; Biotechnology industry Drugs. Azimilide (AZ) is a class III antiarrhythmic drug that has voltage-dependent dual effects on the HERG channel: Dateiformat:

azimilide articles and discussion threads. Learn about and discuss azimilide at The People's Medicine Community. dose of 100 mg azimilide dihydrochloride following an overnight fast. Blood/ plasma and ... The shocking story of azimilide. Circulation 110(24):3624-6 (2004) PMID 15596558 ... Von „http://www.pluspedia.de/index. Dateiformat: von IR Hanna - 2004 - Zitiert durch: Im CacheIngentaConnect Separation and quantitation of azimilide and its ... - [ Diese Seite übersetzen ]von JJ Bao - 1998 - Zitiert durch:

You are trying to access the full-text version of "Azimilide dihydrochloride". At the present time this paper is not available within ResearchGATE. azimilide, Click here to view this ligand in PubChem. IUPHAR-DB Ligand Id: 2588. 2D Structure (Source: PubChem). von CM Pratt - 2004 - Zitiert durch: von J MIAKE - 2004 - Zitiert durch: von AE Busch - 1998 - Zitiert durch: Azimilide is a class III antiarrhythmic agent whose main electrophysiological effect is prolongation of action potential duration.

To assess whether multiple-dose oral co-administration affects the pharmacokinetics (PK) or pharmacodynamics (PD) of azimilide or digoxin.METHODS.

von ELC Pritchett - Zitiert durch:

Appendix: Study Sites and Committees:

zzimilide azimilice azmiilide aimilide xzimilide aaimilide azimiljde azimilidee azimillde azimilkde ezimilide azimilidd azimilude azimilidf wzimilide azimilidi azimil9de aizmilide azimilida azimelide azimilids azimilidu azimliide azimil7de azimilidw azimiilide azimilidde azimilido azimiide azimi/ide azimil8de azimilidr azimillide azimilde aziimlide azimilied az8milide azimiliee azimjlide zimilide azzimilide azimi.ide aziimilide azikilide azim8lide azimiliwe az9milide azlmilide azimilife azimilode azumilide azimilive azimiilde azimklide azimilixe azimildie azimiiide azmilide aximilide szimilide zaimilide azimllide azimi;ide ozimilide azimikide aziilide izimilide azimiliide qzimilide azomilide asimilide azimmilide azimilade azimipide azimi,ide azijilide azimlide azemilide azamilide azi,ilide azjmilide azihilide uzimilide azimilise aazimilide azimilid azim7lide azimalide azimilie azimioide az7milide azimulide azinilide azimilid2 azim9lide azkmilide azimilid3 azimolide azimilid4 azimilire azimilede

About:

Description

Following: